Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

created_at
ingested_at
providers
gdelt
source
manilatimes.net
themes
health
provider_count
1
source_slug
manilatimes-net
url
https://manilatimes.net/2026/08/06/tmt-newswire/globenewswire/harrow-acquires-global-rights-to-tyrvaya-the-first-and-only-fda-approved-nasal-spray-for-dry-eye-disease/2399889
country
Philippines
language
English
org_id
0ac7c1ae-d6eb-4868-9eb4-96b085d4f7ba
dedup_key
f0555333bdb9ab4a
keywords
acquires global, dry eye, eye disease, fda-approved nasal, global rights, harrow acquires, nasal spray, rights tyrvaya, spray dry, tyrvaya fda-approved
last_modified_at
provider
gdelt
feed_section
Business
published_at

Related